down arrow

Xiamen Amoytop Biotech Co. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003RT3
CNY
81.57
8.01 (10.89%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Xiamen Amoytop Biotech Co. Ltd.
Why is Xiamen Amoytop Biotech Co. Ltd. ?
1
The company has declared Positive results for the last 18 consecutive quarters
  • NET SALES(9M) At CNY 2,289.64 MM has Grown at 32.13%
  • NET PROFIT(9M) At CNY 705.37 MM has Grown at 47.07%
  • RAW MATERIAL COST(Y) Fallen by -0.75% (YoY)
2
With ROE of 34.50%, it has a fair valuation with a 11.63 Price to Book Value
  • Over the past year, while the stock has generated a return of 11.57%, its profits have risen by 45.3% ; the PEG ratio of the company is 0.7
  • At the current price, the company has a high dividend yield of 0.8
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Xiamen Amoytop Biotech Co. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Xiamen Amoytop Biotech Co. Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Xiamen Amoytop Biotech Co. Ltd.
-100.0%
1.64
33.82%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
32.36%
EBIT Growth (5y)
49.44%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
1.11
Tax Ratio
10.37%
Dividend Payout Ratio
30.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
40.89%
ROE (avg)
22.33%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
11.63
EV to EBIT
30.11
EV to EBITDA
27.41
EV to Capital Employed
15.01
EV to Sales
10.05
PEG Ratio
0.74
Dividend Yield
0.79%
ROCE (Latest)
49.85%
ROE (Latest)
34.50%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(9M)

At CNY 2,289.64 MM has Grown at 32.13%

NET PROFIT(9M)

At CNY 705.37 MM has Grown at 47.07%

RAW MATERIAL COST(Y)

Fallen by -0.75% (YoY

CASH AND EQV(HY)

Highest at CNY 1,479.9 MM

-4What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 5.07%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.81%

OPERATING PROFIT MARGIN(Q)

Lowest at 31.58 %

Here's what is working for Xiamen Amoytop Biotech Co. Ltd.
Net Sales
At CNY 1,528.23 MM has Grown at 29.54%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Profit
At CNY 455.94 MM has Grown at 45.69%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv
Highest at CNY 1,479.9 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -0.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Xiamen Amoytop Biotech Co. Ltd.
Debtors Turnover Ratio
Lowest at 5.07% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Profit Margin
Lowest at 31.58 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio
Lowest at 0.81%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."